Results 1 to 2 of 2
  1. #1
    News Master TY RSS News's Avatar

    Join Date
    Nov 2013
    Thumbs Up/Down
    Received: 37/0
    Given: 0/0
    Rep Power

    0 Not allowed! Not allowed!

    Default Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

    The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.
    A team of Israeli researchers conducted a randomized placebo-controlled clinical trial to assess the safety and efficacy of a novel, metered-dose cannabis inhaler in 27 patients with chronic pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo.
    They reported: “Both doses, but not the placebo, demonstrated a significant reduction in pain intensity compared with baseline and remained stable for 150-minutes. The 1mg dose showed a significant pain decrease compared to the placebo. Adverse events were mostly mild and resolved spontaneously. There was no evidence of consistent impairments in cognitive performance.”
    Authors concluded: “This feasibility trial demonstrated that a metered-dose cannabis inhaler delivered precise and low THC doses [that] produced a dose-dependent and safe analgesic effect in patients with neuropathic pain/complex-regional pain syndrome (CRPS). Thus, it enables individualization of medical cannabis regimens that can be evaluated pharmacokinetically and pharmacodynamically by accepted pharmaceutical models.”
    Prior clinical trials, such as those here and here, have similarly reported that a metered-dose inhaler can deliver precise therapeutic doses of cannabis to pain patients absent any significant adverse effects.
    Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs. A 2017 literature review by the National Academy of Sciences, Engineering, and Medicine concluded, “There is conclusive or substantial evidence that cannabis or cannabinoids are effective for the treatment of chronic pain in adults.”
    An abstract of the study, “Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial,” is online here. Additional information regarding cannabinoids and pain appears online here.

    Original Article

  2. #2
    Seedling Egzoset's Avatar

    Join Date
    Jun 2012
    Qc, Canada
    Thumbs Up/Down
    Received: 2/0
    Given: 7/0
    Rep Power

    0 Not allowed! Not allowed!



    About cannabis "Metered-Dosing Inhalation", it won't be a surprize if someday this becomes beneficial for everyone, not just people looking for medical applications... After all dosing does shape the ritual which does shape the consumption habit IMO. The finer this dosing granularity shall get the less likely it is to exceed an intoxication threshold ideally limited in some manner to avoid "tolerance" issues, provided there's a desire to do so. Prohibition is no option.

    Nonetheless, when smoking a 300 mg "joint" alone by ourselves it hardly qualifies as dosing at all considering there's no convenient/practical opportunity to consume only what's really useful and/or wanted (e.g. no chance to stop toking before it's much "too late"), recreatively-speaking that is, as some typical party sessions flirt with a need to "Couch-Lock" then eventually have a "T-Break".

    What if future gnerations could finally access proper dosing control that sets them free of problematic consumption habits which bigot anti-cannabic prohibitionists are so quick to label as "ADDICTION", "In The Name Of Children"...

    Good day, have fun!!


Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts